Phase i study of preoperative short-course chemoradiation with proton beam therapy and capecitabine for resectable pancreatic ductal adenocarcinoma of the head

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 1, 2011, Pages 151-157

  Hong, Theodore S ^a   Ryan, David P ^a   Blaszkowsky, Lawrence S ^a   Mamon, Harvey J ^b   Kwak, Eunice L ^a   Mino Kenudson, Mari ^a   Adams, Judith ^a   Yeap, Beow ^a   Winrich, Barbara ^a   Delaney, Thomas F ^a   Fernandez Del Castillo, Carlos ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Chemoradiation; Pancreatic cancer; Pancreaticoduodenectomy; Proton beam; Short course radiotherapy

Indexed keywords

CAPECITABINE; CHEMORADIATION; DOSE LEVELS; DOSE LIMITING TOXICITY; DUCTAL ADENOCARCINOMAS; LENGTH OF STAY; LEVEL 2; LEVEL 4; METASTATIC DISEASE; PANCREATIC ADENOCARCINOMA; PANCREATIC CANCERS; PANCREATICODUODENECTOMY; PHASE I; PHASE II; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CHEMORADIATION; PROTON BEAM THERAPY; SHORT-COURSE RADIOTHERAPY;

CHEMOTHERAPY; PROTON BEAMS; RADIOTHERAPY; SURGERY; TOXICITY;

PROTONS;

BILIRUBIN; CAPECITABINE; GEMCITABINE;

ADULT; ARTICLE; BILE DUCT OBSTRUCTION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; HUMAN TISSUE; LENGTH OF STAY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SHOULDER PAIN; TREATMENT RESPONSE; TUMOR VOLUME; WOUND INFECTION;

AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; COMBINED MODALITY THERAPY; CYTARABINE; DEOXYCYTIDINE; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PRESCRIPTIONS; PROSPECTIVE STUDIES; PROTONS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 78650004783     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.10.061     Document Type: Article

References (27)

1. A. Jemal, R. Siegel, and E. Ward Cancer Statistics 2009 CA Cancer J Clin 59 2009 225 249
2. J.P. Neoptolemos, J.A. Dunn, and D.D. Stocken Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: A randomised controlled trial Lancet 358 2001 1576 1585
3. H. Oettle, S. Post, and P. Neuhaus Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial JAMA 297 2007 267 277
4. S.S. Nitecki, M.G. Sarr, and T.V. Colby Long-term survival after resection for ductal adenocarcinoma of the pancreas: Is it really improving? Ann Surg 221 1995 59 66
5. R.J. Piorkowski, S.W. Believernicht, and W. Lawrence Jr. Pancreatic and periampullary carcinoma: Experience with 200 patients over a 12-year period Am J Surg 143 1982 189 193
6. B. Gudjonsson Cancer of the pancreas: 50 Years of surgery Cancer 60 1987 2284 2303
7. J. Tepper, G. Nardi, and H. Suit Carcinoma of the pancreas: Review of MGH experience from 1963-1973 - analysis of surgical failure and its implications for radiation therapy Cancer 37 1976 1519 1524
8. J.F. Griffin, S.R. Smalley, and W. Jewell Patterns of failure after curative resection of pancreatic carcinoma Cancer 66 1990 56 61
9. Swedish Rectal Cancer Trial group Improved survival with preoperative radiotherapy in resectable rectal cancer N Engl J Med 336 1997 980 987
10. E. Kapiteijn, C.A. Marijnen, and I.D. Nagtegaal Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med 345 2001 638 646
11. K. Bujko, M.P. Nowacki, and A. Nasierowska-Guttmejer Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer Br J Surg 93 2006 1215 1223
12. D. Sebag-Montefiore, R.J. Stephens, and R. Steele Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): A multicentre, randomized Lancet 373 2009 811 820
13. K.R. Kozak, L.A. Kachnic, and J. Adams Dosimetric feasibility of hypofractionated proton radiotherapy for neoadjuvant pancreatic cancer treatment Int J Radiat Biol Phys 68 2007 1557 1566
14. T.M. Breslin, K.R. Hess, and D.B. Harbison Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: Treatment variables and survival duration Ann Surg Oncol 8 2001 123 132
15. Gastrointestinal Study Group Further evidence of effective adjuavant combined radiation and chemotherapy following curative resection of pancreatic cancer Cancer 59 1987 2006 2010
16. W.F. Regine, K.A. Winter, and R.A. Abrams Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: A randomized controlled trial JAMA 299 2008 1019 1026
17. I. Esposito, J. Kleef, and F. Bergmann Most pancreatic cancer resections are R1 resections Ann Surg Oncol 15 2008 1651 1660
18. C.A. Iacobuzio-Donahue, B. Fu, and S. Yachida DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer J Clin Oncol 27 2009 1806 1813
19. S. Connor, L. Bosonnet, and P. Ghaneh Survival of patients with periampullary carcinoma is predicted by lymph node 8a but not by lymph node 16b1 status Br J Surg 91 2004 1592 1599
20. M.L. Foo, L.L. Gunderson, and D.N. Nagorney Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil Int J Radiat Oncol Biol Phys 26 1993 483 489
21. J.A. Hattangadi, T.S. Hong, B.Y. Yeap, and H.J. Mamon Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma Cancer 115 2009 3640 3650
22. J.P. Hoffman, S. Lipsitz, and T. Pisansky Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An Eastern Cooperative Oncology Group Study J Clin Oncol 16 1998 317 323
23. F.R. Spitz, J.L. Abbruzzese, and J.E. Lee Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas J Clin Oncol 15 1997 928 937
24. J.M. Herman, M.J. Swartz, and C.C. Hsu Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: Results of a large, prospectively collected database at the Johns Hopkins Hospital J Clin Oncol 26 2008 3503 3510
25. M.M. Corsini, R.C. Miller, and M.G. Haddock Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: The Mayo Clinic experience 1975-2005 J Clin Oncol 26 2008 3511 3516
26. A.R. Sasson, R.W. Wetherington, and J.P. Hoffman Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: Analysis of histopathology and outcome Int J Gastrointest Cancer 34 2003 121 128
27. H. Birgisson, L. Pahlman, U. Gunnarsson, and B. Glimelius Adverse effects of preoperative radiation therapy for rectal cancer: Long-term follow-up of the Swedish Rectal Cancer Trial J Clin Oncol 23 2005 8697 8705